# Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations

> **NCT07320001** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Basharat Hussain** · enrollment: 92 (estimated)

## Conditions studied

- Lymphatic Abnormality

## Interventions

- **DRUG:** Bleomycin
- **DRUG:** doxycycline (tetracycline)

## Key facts

- **NCT ID:** NCT07320001
- **Lead sponsor:** Basharat Hussain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2026-07-26
- **Final completion:** 2026-09-26
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320001, "Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07320001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*